RxCelerate
Sanchari Roy, PhD, is an accomplished Senior Scientist and Project Leader at RXCELERATE LIMITED since April 2022, previously serving as a Team Leader and R&D Scientist at DefiniGEN from January 2019 to April 2022. Sanchari held a postdoctoral research position at Uniklinik RWTH Aachen from April 2014 to December 2018, focusing on high-throughput PCR-based gene profiling in liver cancer, assay development, and target validation. Educational credentials include a PhD in Cell/Cellular and Molecular Biology from Heidelberg University, an MSc in Molecular Biology from the University of Hertfordshire, and a B.Tech in Industrial Biotechnology from Anna University Chennai. Sanchari possesses extensive expertise in cell culture, biochemical assays, molecular biology methods, and high-throughput screening, complemented by proficiency in data interpretation and bioinformatics.
This person is not in any teams
RxCelerate
1 followers
RxCelerate Limited is a leading outsourced drug development company based in Cambridge (U.K) delivering complete preclinical programmes to our clients. We offer a comprehensive suite of services under one roof, including in silico modelling, medicinal chemistry, in vitro and preclinical capabilities, and project management. We pride ourselves on our ability to deliver innovative cutting-edge experimental solutions that save our clients time and money. Our flexible approach, commitment to quality, and ability to deliver results quickly make us the perfect partner for unlocking the true potential of your drug development journey. We are not just a company; we are a people-first organisation. We invest in and value our employees and have created an environment that encourages collaboration, innovation and personal growth. We foster a culture of inclusivity, where every team member’s voice is heard, and their ideas are valued. Connect with us to be part of our exciting journey!